BE838507A - Comprimes pharmaceutiques - Google Patents

Comprimes pharmaceutiques

Info

Publication number
BE838507A
BE838507A BE164281A BE164281A BE838507A BE 838507 A BE838507 A BE 838507A BE 164281 A BE164281 A BE 164281A BE 164281 A BE164281 A BE 164281A BE 838507 A BE838507 A BE 838507A
Authority
BE
Belgium
Prior art keywords
pharmaceutical tablets
tablets
pharmaceutical
Prior art date
Application number
BE164281A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE838507A publication Critical patent/BE838507A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE164281A 1975-02-13 1976-02-12 Comprimes pharmaceutiques BE838507A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6174/75A GB1533243A (en) 1975-02-13 1975-02-13 Tablet formulation

Publications (1)

Publication Number Publication Date
BE838507A true BE838507A (fr) 1976-08-12

Family

ID=9809772

Family Applications (1)

Application Number Title Priority Date Filing Date
BE164281A BE838507A (fr) 1975-02-13 1976-02-12 Comprimes pharmaceutiques

Country Status (14)

Country Link
JP (1) JPS51106711A (fr)
BE (1) BE838507A (fr)
CA (1) CA1052267A (fr)
DE (1) DE2605656A1 (fr)
DK (1) DK57376A (fr)
FI (1) FI760340A (fr)
FR (1) FR2300550A1 (fr)
GB (1) GB1533243A (fr)
HU (1) HU171201B (fr)
IE (1) IE42952B1 (fr)
IL (1) IL49024A (fr)
NL (1) NL7601423A (fr)
SE (1) SE7601564L (fr)
ZA (1) ZA76829B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
NL9220009A (nl) * 1991-01-30 1993-11-01 Wellcome Found In water-dispergeerbare tabletten.
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1460302A (en) * 1973-05-23 1977-01-06 Wellcome Found Tablet formulation
GB1499672A (en) * 1974-02-14 1978-02-01 Wellcome Found Tablet formulation

Also Published As

Publication number Publication date
IE42952B1 (en) 1980-11-19
GB1533243A (en) 1978-11-22
IL49024A0 (en) 1976-04-30
FR2300550B1 (fr) 1979-09-21
FI760340A (fr) 1976-08-14
FR2300550A1 (fr) 1976-09-10
SE7601564L (sv) 1976-08-16
CA1052267A (fr) 1979-04-10
IL49024A (en) 1979-03-12
ZA76829B (en) 1977-09-28
NL7601423A (nl) 1976-08-17
AU1110876A (en) 1977-08-18
IE42952L (en) 1976-08-13
HU171201B (hu) 1977-11-28
DE2605656A1 (de) 1976-08-26
JPS51106711A (fr) 1976-09-21
DK57376A (da) 1976-08-14

Similar Documents

Publication Publication Date Title
SE423967B (sv) Forfarande for framstellning av porosa tabletter
DK533476A (da) Kapsler
SE7601463L (sv) Brusande dipeptidsotningsmedelstabletter
NL7514012A (nl) Farmaceutische capsules.
BE852444A (fr) Compositions pharmaceutiques anti-inflammatoires
NL7801187A (nl) Farmaceutisch tablet.
SE7709359L (sv) Farmaceutisk doseringsform
NL7614262A (nl) Kauwbare tablet.
BR7600226A (pt) Conjunto de medicao
BE851590A (fr) Compositions pharmaceutiques renfermant des pyrethrinoides
FR2304354A1 (fr) Nouvelles compositions pharmaceutiques a activite retardee
BE871584A (fr) Preparations pharmaceutiques
IL51096A0 (en) Novel pharmaceutical dosage form
DK264576A (da) Skruekapsellukke
DK90376A (da) Medicinpakning
SE7609339L (sv) Farmaceutiska bassalter
SE408266B (sv) Narkosmedelavdunstare
AU504182B2 (en) Pharmaceutical dosage forms
BE826935A (fr) Compositions pharmaceutiques antivirales
SE7608478L (sv) Farmaceutica
FI763506A (fi) Farmaceutisk naeringsfoerpackning
BE838507A (fr) Comprimes pharmaceutiques
FR2326189A2 (fr) Composition pharmaceutique
BE816376A (fr) Compositions pharmaceutiques a base de creatine-phosphate et decreatine-phosphokinase
SE7600480L (sv) Farmaceutiskt anvendbara 2-aminoacetamido-alfa-fenylbensylidenaminoalk